Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Fukuoka S, Hara H, Takahashi N, Kojima T, Kawazoe A, Asayama M. et al.
Regorafenib plus nivolumab in patients with advanced gastric or colorectal cancer: An open-label, dose-escalation, and dose-expansion phase Ib trial (REGONIVO, EPOC1603).

J Clin Oncol 2020;
38: 2053-61

Bibliographische Angaben herunterladen

Aufrufen in: